Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-08-26 Sale | 2021-08-30 5:16 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 7,714 | $35.75 | $275,787 | 232,970 (Direct) | View |
| 2021-08-13 Sale | 2021-08-17 4:44 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 2,286 | $35.07 | $80,161 | 250,324 (Direct) | View |
| 2021-07-27 Sale | 2021-07-29 7:27 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 20,000 | $35.47 | $709,380 | 209,380 (Direct) | View |
| 2021-05-07 Sale | 2021-05-11 6:46 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 10,000 | $40.82 | $408,192 | 229,380 (Direct) | View |
| 2021-04-08 Sale | 2021-04-15 7:14 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 4,630 | $38.34 | $177,504 | 239,380 (Direct) | View |
| 2021-04-07 Sale | 2021-04-09 5:55 pm | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 15,370 | $39.31 | $604,144 | 244,010 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award | 2024-03-04 6:07 pm | N/A 2034-02-28 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-02-07 Option Award | 2023-02-09 4:08 pm | N/A 2033-02-06 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 135,000 | $0 | 135,000 (Direct) | View |
| 2022-02-15 Option Award | 2022-02-17 7:12 pm | N/A 2032-02-14 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 100,000 | $0 | 100,000 (Direct) | View |
| 2021-08-26 Exercise | 2021-08-30 5:16 pm | N/A 2028-11-12 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 7,714 | $0 | 232,970 (Direct) | View |
| 2021-08-26 Exercise | 2021-08-30 5:16 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 7,714 | $1.43 | 232,970 (Direct) | View |
| 2021-08-13 Exercise | 2021-08-17 4:44 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 558 | $1.89 | 250,324 (Direct) | View |
| 2021-08-13 Exercise | 2021-08-17 4:44 pm | N/A 2030-03-26 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 2,286 | $0 | 250,324 (Direct) | View |
| 2021-08-13 Exercise | 2021-08-17 4:44 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 1,728 | $1.43 | 250,324 (Direct) | View |
| 2021-07-27 Exercise | 2021-07-29 7:27 pm | N/A 2028-11-12 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 20,000 | $0 | 209,380 (Direct) | View |
| 2021-07-27 Exercise | 2021-07-29 7:27 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 20,000 | $1.43 | 209,380 (Direct) | View |
| 2021-07-20 Option Award | 2021-07-22 6:17 pm | N/A 2031-07-19 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 95,000 | $0 | 95,000 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 6:46 pm | N/A 2028-11-12 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 10,000 | $0 | 229,380 (Direct) | View |
| 2021-05-07 Exercise | 2021-05-11 6:46 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 10,000 | $1.43 | 229,380 (Direct) | View |
| 2021-04-08 Option Award | 2021-04-15 7:14 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 4,630 | $1.43 | 239,380 (Direct) | View |
| 2021-04-08 Exercise | 2021-04-15 7:14 pm | N/A 2028-11-12 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 4,630 | $0 | 239,380 (Direct) | View |
| 2021-04-07 Option Award | 2021-04-09 5:55 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 15,370 | $1.43 | 244,010 (Direct) | View |
| 2021-04-07 Exercise | 2021-04-09 5:55 pm | N/A 2028-11-12 | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 15,370 | $0 | 244,010 (Direct) | View |
Ownership | 2020-09-24 7:29 pm | N/A N/A | Prelude Therapeutics Inc | PRLD | Scherle Peggy Chief Scientific Officer | 0 | $0 | 531,728 (Direct) | View |